CharlieAJA/iStock via Getty Images Ginkgo Bioworks (NYSE:DNA) lost ~11% premarket Friday after the cell platform company slashed its full-year revenue…
Read More »Bioworks
Dive Brief: Biotech companies Phytolon and Ginkgo Bioworks announced a new milestone in their mission to scale cell-engineered natural colors…
Read More »